![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Fcontent%2Fvol9%2Fissue9%2Fimages%2Fmedium%2Ffdt0005f1.gif)
Reduction in the relative risk of invasive breast cancer among healthy female populations at increased risk, calculated in the NSABP P-1 trial. LCIS indicates lobular carcinoma in situ; AH, atypical hyperplasia; and NSABP, National Surgical Adjuvant Breast and Bowel Project.